Bath & Body Works earnings analysis: questions answered and next catalysts

Bath & Body Works reported a remarkable second-quarter earnings surprise, with earnings per share (EPS) coming in at $0.62, a striking 158% increase over the expected $0.24. This surge was primarily fueled by an unexpected $80 million tariff refund, which boosted margins by 530 basis points. Adjusting for this, the adjusted EPS was $0.31, which still outperformed analysts' expectations but also highlighted the challenges the company faces as it undergoes transformation.

Following the earnings beat, the stock price saw a 7.57% increase, closing at $18.91 and the company raised its full-year EPS guidance to $2.60-$2.80, signaling confidence in their ability to absorb future tariff volatility while funding their "Consumer First Formula" initiatives.

The Q3 guidance, however, was less optimistic, with analysts expecting EPS between $0.07 and $0.12, significantly lower than the consensus estimate of $0.26. This suggests management anticipates headwinds. The earnings call provided clarity on one key question: the extent of the company's cushion. The $80 million tariff refund was unexpected and played a crucial role in transforming a mediocre quarter into a strong beat.

Without this, gross margins would have been around 40.4% instead of 45.7%, and EPS would have been $0.31 instead of $0.62.

The refund offers the company time to navigate the transformation process. Management has raised full-year EPS guidance, indicating confidence in their ability to manage future tariff volatility and fund their strategic transformation. Another question answered was regarding the source of growth. The answer indicates a bifurcated business structure: The company's "Free Shipping over $50" initiative, which started in Q4 2025, is cannibalizing in-store sales but is boosting direct margins.

Amazon sales tripled from Q1 to Q2, positioning BBWI as a top candle brand on the platform. However, the tension lies in the fact that store closures, with 10 closures versus 24 openings, mostly off-mall, are strategic moves but are creating a revenue gap.

Looking ahead, the Q3 guidance set by management points to a challenging path. They forecast a sales decline of 2.5%-5% and EPS between $0.07 and $0.12, which is still lower than the consensus estimate of $0.26. The critical test will come in Q3 2026 with the release of the Q3 results. If the company can beat this low bar, sentiment could shift positively.

However, miss this target, and the transformation narrative could crumble. The holiday performance in 2026, particularly around Black Friday and Christmas, will be crucial to see if the digital pivot and product innovations, such as the Reserve Collection home fragrance and the A Thousand Wishes refresh, can offset the erosion in store traffic.

Ultimately, the inflection point for the company's transformation is expected to become more significant in 2027. Analysts project revenue to stabilize at $7.10 billion and EPS to recover to $2.85. Currently, Bath & Body Works trades at around $18.91, with Citi upgrading the stock to Buy with a $25 target, citing compelling risk-reward after a 44% stock decline over the past 12 months.

JPMorgan maintains a Neutral rating at $24. The general consensus among analysts is a mix of 4 Buy, 13 Hold, and 1 Sell. The bull case for the stock includes the possibility of recurring tariff refunds, accelerated digital growth, international expansion, and meaningful transformation impact in 2027. However, the bear case suggests that the beat in Q2 may have been a one-time windfall, with store traffic stability remaining uncertain, and the transformation taking longer than anticipated.

The company's $4.71 billion debt load also limits its flexibility. Despite the stock appearing cheap with a low valuation multiple of 5.2x earnings and a 4.6% yield, the declining revenue trend over the past three years and the lack of near-term revenue inflection point raise concerns. The next 90 days, particularly the Q3 results and holiday sales performance, will be crucial in determining whether this is a value trap or a genuine investment opportunity.